Research and innovation in the development of everolimus for oncology

By Lebwohl David   Thomas George   Lane Heidi A   O'Reilly Terence   Escudier Bernard   Yao James C   Pavel Marianne   Franz David   Berg William   Baladi Jean-Francois   Stewart Jubilee   Motzer Robert J  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 3, 2011-03 ,pp. : 323-338

Informa Healthcare

Access to resources Recommend Favorite

The Future Contribution of China to Medicines Development and Human Subjects Protections

By Crawley Francis P.  

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 6, 2006-01 ,pp. : 353-354

Adis International

Access to resources Recommend Favorite

The World Health Organization's Essential Medicines List: An Endorsement of Incremental Innovation and Follow-On Research

By Wertheimer Albert I.   Santella Thomas M.   Chaney Nicole M.  

Journal of Pharmaceutical Marketing & Management, Vol. 17, Iss. 2, 2007-02 ,pp. : 25-34

Haworth Press

Access to resources Recommend Favorite

Open innovation: the new face of pharmaceutical research and development

By Getz Kenneth A   Kaitin Kenneth I  

Expert Review of Clinical Pharmacology, Vol. 5, Iss. 5, 2012-09 ,pp. : 481-483

Informa Healthcare

Access to resources Recommend Favorite

China to cut prices on over 2300 essential medicines

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 590, 2009-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite